Related by context. All words. (Click for frequent words.) 72 haematologic 68 tumoral 68 hematological 68 histologic subtype 68 unfavorable cytogenetics 67 papillary renal cell carcinoma 67 gastric carcinoma 67 myeloproliferative neoplasms 67 myeloproliferative diseases 67 pheochromocytoma 66 sarcomatoid 66 elevated ALT 66 hepatorenal syndrome 66 essential thrombocythemia 66 mucinous 66 hematopoietic cancers 66 scintigraphic 66 sCJD 66 pretransplant 65 erythropoietic 65 thyroid carcinoma 65 bronchoalveolar lavage 65 cytopenias 65 pleural fluid 65 AST ALT 65 renal cell carcinomas 65 aminotransferase 65 antiphospholipid syndrome 65 histologies 65 neoplastic 65 endometrioid 65 gastrointestinal stromal tumors GISTs 65 clinico pathological 65 immunostaining 65 immunohistochemical 65 hematologic toxicity 65 carcinoids 65 genotypic resistance 65 relapsed MM 65 cytogenic 65 galiximab 65 lymphocytosis 65 serum cortisol 65 lesional 64 histopathological 64 hepatic cirrhosis 64 deletion 5q 64 hematologic 64 histological subtype 64 lactate dehydrogenase LDH 64 Sjögren syndrome 64 tumor necrosis 64 pathologic examination 64 hamartomas 64 urothelial 64 lymphoproliferative disorders 64 SSc 64 alkaline phosphatase 64 abnormal cytology 64 HIV HCV coinfected 64 haematopoietic 64 HSCT 64 plasma creatinine 64 pT3 64 skeletal metastases 64 glomerular filtration 64 BCR ABL mutations 64 Hematologic 64 neutropaenia 64 response pCR 64 breast carcinoma 64 ALT flares 64 cytological 64 Histologic 64 parenteral antibiotics 64 histologic 64 HER2 overexpression 64 mycosis fungoides 64 myeloablative 64 hemolytic 64 hepatic enzymes 64 extramedullary 64 clinicopathological 63 B7 H3 63 hepatocellular carcinomas 63 postoperative chemotherapy 63 lymphocytic 63 epithelial tumors 63 liver histology 63 immune modulating 63 immunotoxicity 63 ara C 63 autoimmune hemolytic anemia 63 LVNC 63 idiopathic myelofibrosis 63 GH deficiency 63 inflammatory biomarkers 63 K ras mutations 63 intracranial hemorrhage ICH 63 tryptase 63 serous ovarian cancer 63 bovine thrombin 63 metastatic neuroendocrine tumors 63 HRCT 63 HeFH 63 affective psychosis 63 histopathologic examination 63 sonographic diagnosis 63 histologic examination 63 leukocytosis 63 SGPT 63 clinicopathologic 63 thrombocytopenic 63 intact parathyroid hormone 63 MGd 63 adverse cytogenetics 63 HER2 expression 63 metaplasia 63 surgically resectable 63 bronchogenic carcinoma 63 etiologic 63 BEXXAR Therapeutic Regimen 63 papillary carcinoma 63 ANCA associated 63 cardiac troponin 63 riociguat 63 peritoneal fluid 63 HGPIN 63 CLA isomers 63 carcinoembryonic antigen 63 plasma lipid 63 EGFR HER2 63 neutrophil counts 63 NPM1 mutation 62 mucosal inflammation 62 elevated LDH 62 myelofibrosis polycythemia vera 62 thrombophilia 62 FluCAM arm 62 inotropic 62 malignant neoplasms 62 cerebrospinal fluid CSF 62 atherogenic dyslipidemia 62 autonomic dysfunction 62 AGHD 62 immunopathology 62 colorectal carcinoma 62 PNH patients 62 de novo AML 62 lymphopenia 62 serum lipid levels 62 Aplidin 62 partial remissions 62 urolithiasis 62 serum ferritin 62 LHRH receptor positive 62 lymphoid tumors 62 nonalcoholic steatohepatitis NASH 62 NMIBC 62 affective psychoses 62 urine cytology 62 relapsed ALL 62 seropositivity 62 hypothalamic pituitary 62 pT2 62 metabolomic profiles 62 histologic subtypes 62 Immunohistochemical staining 62 neutropenia thrombocytopenia 62 erythropoiesis 62 Chronic Prostatitis 62 alanine aminotransferase 62 thromboembolic 62 allogeneic transplant 62 osteosarcomas 62 Xanafide 62 thyroglobulin 62 QTc prolongation 62 hematologic parameters 62 glycosylated hemoglobin HbA1c 62 oncologic outcomes 62 pilocytic astrocytomas 62 serum antibody 62 neurosensory 62 heparanase 62 serum PTH 62 TPMT 62 squamous intraepithelial lesions 62 demyelinating 62 proctitis 62 prostate carcinoma 62 von Willebrand 62 colorectal adenoma 62 resected pancreatic cancer 62 echocardiographic parameters 62 hA# 62 circulating endothelial cells 62 specific antigen PSA 62 β blockers 62 TRAIL R1 62 follicular lymphoma FL 62 peripheral blood mononuclear 62 cTnI 62 intravesical therapy 62 airway hyperresponsiveness 62 granulocyte 62 serum lipid 62 chronic GVHD 62 Cardiotoxicity 62 pharmacokinetic parameters 62 G6PD deficiency 62 stratifying patients 62 bFGF 62 carcinomatosis 62 CIN2 + 62 ON #.Na 62 aspartate aminotransferase AST 62 intestinal permeability 62 renal transplants 62 carcinoid 62 T2DM 62 polycythemia vera PV 62 Histopathological 62 euthymic patients 62 multicentric 62 troponin T 62 tumor histology 62 nodal metastasis 62 IL 1ß 62 basal cell carcinoma BCC 62 Histological 62 electrophysiologic 62 Serological 62 neovascular 62 hepatic enzyme 62 seminomas 62 stem cell transplantations 62 leiomyomas 62 Natalizumab 62 tissue oxygenation 62 prospectively enrolled 62 Triapine R 62 pancreatic adenocarcinoma 61 anemia neutropenia 61 alanine aminotransferase ALT 61 normal karyotype 61 inducible nitric oxide synthase 61 bacterial prostatitis 61 eosinophilia 61 Leydig cell 61 anti JCV antibodies 61 receptor tyrosine kinase inhibitor 61 eculizumab therapy 61 bioavailable testosterone 61 radiotherapy RT 61 serologic tests 61 locoregional recurrence 61 CTEPH 61 baseline LDH 61 carotid stenosis 61 endotoxemia 61 percutaneous drainage 61 STRIDE PD 61 urodynamic 61 hematological parameters 61 SUVmax 61 immunohistochemical staining 61 allogeneic HSCT 61 N telopeptide 61 Microalbuminuria 61 kidney urologic 61 hyperphenylalaninemia HPA due 61 recurrent glioblastoma multiforme 61 PSA nadir 61 neoplasm 61 lymphomas leukemias 61 gonococcal 61 intracerebral haemorrhage 61 chest radiograph 61 malignant ascites 61 myeloproliferative disorders 61 demonstrated antitumor activity 61 SJIA 61 Ribavirin causes 61 haematological cancers 61 troponins 61 pituitary hormone 61 ER CHOP 61 cellularity 61 calcineurin inhibitor 61 serologic 61 interferon IFN 61 T1DM 61 CIMZIA TM certolizumab pegol 61 neoplasms 61 atrioventricular block 61 vWF 61 CIN3 61 Leukemias 61 astrocytomas 61 histopathologic 61 Gleevec resistant 61 posttreatment 61 atypical hemolytic uremic syndrome 61 macroalbuminuria 61 bronchoalveolar 61 Cyclin E 61 splenic 61 dysglycemia 61 prospective multicenter study 61 Alkaline Phosphatase 61 cytologic 61 overt hypothyroidism 61 intravenous bisphosphonates 61 porcine derived 61 Hurthle cell 61 methotrexate therapy 61 plasma lipoprotein 61 SCr 61 ABL1 61 acute GvHD 61 syndromic 61 gastric adenocarcinoma 61 follicular lymphomas 61 cholestasis 61 Chronic lymphocytic leukemia 61 karyotypes 61 kinase inhibition 61 osteoblastic 61 haematological malignancies 61 neutropenia dehydration dyspnea 61 transaminase elevations 61 cranial irradiation 61 paragangliomas 61 plasma pharmacokinetics 61 antitumor effect 61 IPAH 61 reticulocytes 61 plasma cortisol 61 bronchial epithelial cells 61 thymectomy 61 IgG4 61 isoenzyme 61 p# biomarker 61 MYCAMINE 61 HBsAg 61 clinicopathological features 61 pharmacodynamic parameters 61 granulomatous 61 retrospective cohort 61 T1c 61 Lp PLA 2 61 basophils 61 invasive carcinomas 61 trastuzumab Herceptin ® 61 LHRH agonists 61 aetiology 61 unfavorable prognostic 61 EGFRIs 61 autologous SCT 61 hemorrhagic cystitis 61 antibody titer 61 neuropathologic 61 artery stenosis 61 Darinaparsin 61 hematopoietic malignancies 61 elevated bilirubin 61 hypercholesterolaemia 61 glomerular 61 thrombocytosis 61 calcineurin inhibitors 61 immunomodulation 61 seminoma 61 T1a 61 busulfan 61 KRAS status 61 extracranial 61 apolipoproteins 61 pancytopenia 61 NRTI resistance 61 neurological manifestations 61 cytostatic 61 moderately emetogenic 61 sJIA 61 NAGS deficiency 61 pulmonary hypertension PH 61 synovial 61 somatosensory evoked potentials 61 thalidomide Thalomid 61 myeloperoxidase 60 tTG 60 mRNA expression 60 ERBB2 60 transgene expression 60 hematopoietic 60 TMPRSS2 ERG fusion 60 tigecycline 60 IgE antibody 60 ABCB1 60 SSc patients 60 lactate dehydrogenase 60 erythrocyte sedimentation rate 60 amnestic 60 CLL SLL 60 HCV antibody 60 ERK signaling 60 cTnT 60 erythema nodosum 60 paroxysmal nocturnal hemoglobinuria 60 steroid dexamethasone 60 prognostic indicators 60 urothelial carcinoma 60 vitamin B# folic acid 60 TNFalpha 60 SLNB 60 MALT lymphoma 60 microsatellite instability 60 grade cervical intraepithelial 60 remission CR 60 smoldering multiple myeloma 60 metastatic lesions 60 smoldering myeloma 60 liver metastasis 60 Enzastaurin 60 monoclonal gammopathy 60 aspartate aminotransferase 60 urine NGAL 60 nephrogenic 60 oral Hycamtin 60 adenomatous 60 intravascular hemolysis 60 cutaneous squamous cell carcinoma 60 calculi 60 hyper IgE syndrome 60 RQ PCR 60 definite stent thrombosis 60 metastatic malignant melanoma 60 effector function 60 biochemical abnormalities 60 hypophosphatemia 60 monocytic 60 Secondary efficacy endpoints 60 bullous 60 ependymomas 60 colorectal adenocarcinoma 60 Immunohistochemical analysis 60 systemic mastocytosis 60 hypericin 60 PAOD 60 CsA 60 enzyme inhibition 60 rFVIIa 60 liver biopsies 60 leukaemias 60 exploratory endpoints 60 carcinoid tumors 60 hemoglobin Hb 60 acute myeloid 60 corneal epithelial 60 lenalidomide dexamethasone 60 nodal metastases 60 chest radiographs 60 isotypes 60 lymphadenopathy 60 Gram stain 60 Cloretazine 60 posttransplant 60 maternal serum 60 tipranavir ritonavir 60 overt nephropathy 60 immune dysregulation 60 vasoactive 60 CORE OM 60 pharmacodynamic endpoints 60 pericardial effusion 60 bezafibrate 60 ADPKD 60 alkylating 60 undetectable HBV DNA 60 operable breast cancer 60 anogenital warts 60 neutropenic patients 60 metastatic GIST 60 CLORETAZINE TM VNP#M 60 proliferative retinopathy 60 telomere lengths 60 mTOR inhibitors 60 elevated creatinine 60 Sezary syndrome 60 Cystatin C 60 H#K#me# 60 GAMMAGARD 60 euthyroid 60 multiple myeloma MM 60 immunochemical fecal occult 60 anti angiogenic agents 60 D Dimer 60 completely resected 60 gastroduodenal 60 hemoglobin hematocrit 60 thyrotropin 60 CRp 60 prospectively stratified 60 microRNA expression 60 cytogenetic abnormalities 60 hydroxy vitamin D 60 MGUS 60 renal allograft 60 florbetaben 60 lenalidomide Revlimid R 60 squamous 60 primary aldosteronism 60 System IPSS 60 triiodothyronine 60 cystic fibrosis chronic pancreatitis 60 Histopathologic 60 prucalopride 60 immunoreactivity 60 nephrotoxicity 60 primary hyperparathyroidism 60 antemortem 60 hypereosinophilic syndrome 60 hypogonadotropic hypogonadism 60 immunosuppressive agents 60 malignant lymphomas 60 melphalan prednisone 60 thyroid stimulating hormone TSH 60 TURBT 60 antiangiogenic therapy 60 renal tumors 60 endothelial activation 60 Squamous 60 sitosterol 60 severe hypersensitivity reactions 60 enteroviral infection 60 hepatic fibrosis 60 polycythemia vera essential thrombocythemia 60 lipid lowering agents 60 antitumour activity 60 sargramostim 60 pituitary adenomas 60 pCR 60 liposomal amphotericin B 60 neuroendocrine cancers 60 aplasia 60 adducts 60 histologic findings 60 serotonin synthesis 60 haemolysis 60 antiangiogenic agents 60 proton MR spectroscopy 60 pulmonary metastases 60 homocysteine concentrations 60 Acute myeloid leukemia 60 CYT# potent vascular disrupting 60 supernatants 60 Thalomid ® 60 C1q 60 anagrelide 60 pleomorphic 60 fluvastatin 60 mutated K ras 60 metastatic prostate 60 polyarticular 60 pancreatic insufficiency 60 histologically confirmed 60 D dimer 60 Myelosuppression 60 localized renal 60 radiographic findings 60 tumor lysis syndrome 60 myelodysplastic myeloproliferative diseases 60 E. faecalis 60 colorectal liver metastases 60 mononuclear 60 tumor xenograft models 60 Vidaza ® 60 serum TSH 60 metastatic malignant 60 eosinophilic asthma 60 pleurodesis 60 parathyroid 60 Prostatitis 59 replicon 59 Clusterin 59 tumorigenicity 59 Creatinine 59 genitourinary cancers 59 clevidipine 59 MYLOTARG 59 adjuvant systemic 59 tumor biopsies 59 serum urate levels 59 TGF ß1 59 oral FTY# 59 neutrophil count 59 thorough QT 59 prognostic significance 59 neurocognitive impairment 59 serum PSA 59 lung fibrosis 59 cardiogenic 59 metastatic lymph nodes 59 ritonavir boosted 59 prospectively defined 59 hypercoagulable 59 serum aminotransferase levels 59 pharmacodynamic PD 59 bladder carcinoma 59 nonischemic 59 chronic myeloid 59 apolipoprotein B 59 paraneoplastic 59 irbesartan 59 idiopathic thrombocytopenic purpura 59 cytotoxicity assays 59 Circulating tumor cells 59 bronchoalveolar lavage BAL 59 Lymphoid 59 chromosomal aberrations 59 renal carcinoma 59 malignant lymphoma 59 clonal expansion 59 prostate cancer PCa 59 alkaline phosphatase ALP 59 ERalpha 59 lymphoid malignancies 59 saline infusion 59 complement inhibitor eculizumab 59 K RAS 59 cardiac biomarkers 59 urinary N telopeptide 59 haematopoietic stem cell 59 antineoplastic 59 intraobserver 59 induced sputum 59 villous atrophy 59 acute aortic dissection 59 missense mutations 59 preterm newborns 59 Pseudomonas aeruginosa infections 59 lymphovascular invasion 59 immunohistochemical analysis 59 intra abdominal infections 59 transaminase levels 59 ADAMTS# 59 bone scintigraphy 59 NNRTI resistance 59 Fas ligand 59 FXIII 59 anthracycline chemotherapy 59 antiphospholipid antibodies 59 immunological responses 59 cerebral angiography 59 malignant prostate 59 chromosomal rearrangement 59 ^ sup #m 59 cervicitis 59 coinfected patients 59 pathogenetic 59 CC genotype 59 myeloproliferative 59 histologically proven 59 lymphoma subtypes 59 IGFBP 3 59 INCB# [003] 59 serum phosphate 59 Intravenous immunoglobulin 59 sonographically guided 59 corticosteroid dose 59 polyposis 59 atherothrombotic 59 vascularisation 59 epoetin alpha 59 ertapenem 59 latent celiac disease 59 alveolar epithelial cells 59 biliary tract cancer 59 PsA 59 NMDA antagonists 59 BRAF V#E mutation 59 immuno modulatory 59 radioiodine therapy 59 VP# [004] 59 Adenomas 59 flavopiridol 59 somatic mutations 59 #beta 59 p# antigen 59 chemoprevention trials 59 gastric mucosa 59 Fludara ® 59 amenorrhoea 59 invasive ductal 59 IFN α 59 azoospermia 59 p# activation 59 tumor regressions 59 atrophic gastritis 59 bronchoalveolar lavage fluid 59 hypoperfusion 59 imipenem 59 antibiotic regimens 59 benign neoplasms 59 eosinophil count 59 thromboembolic disease 59 subclinical disease 59 Medullary thyroid cancer 59 β amyloid 59 somatostatin analogs 59 postoperative complication 59 spirometric 59 renal biopsy 59 dosimetric 59 endoglin 59 concomitant medications 59 esophageal carcinoma 59 hyperoxaluria 59 autologous transplantation 59 malignant pleural mesothelioma 59 humoral responses 59 CANCIDAS 59 airway responsiveness 59 basal cell nevus syndrome 59 ELISpot 59 serum lactate 59 Subgroup analyzes 59 penetrance 59 Endothelial dysfunction 59 membranous nephropathy 59 microdeletion 59 platelet reactivity 59 microalbumin 59 Inhibin B 59 Raptiva ® 59 CIMZIA ™ 59 p = #.# [003] 59 murine models 59 rFSH 59 lung carcinomas 59 serum IgG 59 microRNA profiling 59 cytoreduction 59 unknown etiology 59 metabolite concentrations 59 duplex ultrasonography 59 histological examination 59 meta regression 59 clomipramine 59 systemic amyloidosis 59 myocardial ischaemia 59 transplantation HCT 59 left ventricular diastolic 59 quantitative PCR 59 liver transplant recipients 59 FDG-PET/CT 59 leiomyoma 59 autoimmune thyroid 59 pathophysiological mechanisms 59 postintervention 59 EpCAM expression 59 interstitial pneumonia 59 HbF 59 gemcitabine carboplatin 59 thyroid stimulating hormone 59 BR.# 59 bronchial hyperresponsiveness 59 YONDELIS 59 SIADH 59 familial clustering 59 ultrastructural 59 immunosuppression therapy 59 sacral neuromodulation 59 ocular disorders 59 Estrogen Receptor 59 immunofluorescent 59 fosbretabulin 59 intravenous cyclophosphamide 59 SNT MC# 59 comparator arm 59 CMV infection 59 lymphocyte count 59 underwent coronary angiography 59 affective disorders 59 Cardiac Troponin 59 underwent resection 59 Doxil ® 59 graft dysfunction 59 prostate cancer CaP 59 bone marrow suppression 59 metabolic parameters 59 germline mutation 59 pyelonephritis 59 hypervascular 59 interleukin IL -6 59 hyperprolactinemia 59 neovascularisation 59 transaminase 59 HBeAg 59 genitourinary GU 59 BrachySil TM 59 postinjury 59 somatoform disorders 59 invasive candidiasis 59 lymphoid 59 immunoglobulin G 59 neurocognitive function 59 #F FDG 59 prognostic biomarker 59 folinic acid 59 serological tests 59 pharmacokinetic interactions 59 μg L 59 neuritic 59 Lymph node 59 hematological diseases 59 lobular carcinomas 59 Hypotension 59 sPLA2 59 psychiatric morbidity 59 leukocyte count 59 papillary thyroid carcinoma 59 Xelox 59 transabdominal 59 Antisoma AS# 59 Lymphocytic 59 TNF antagonist 59 azacytidine 59 FLT3 59 Primary endpoints 59 Hurler syndrome 59 antiangiogenic activity 59 transaminases 59 TIMP 1 59 pmol L 59 IL#B 59 MCyR 59 steroidogenic 59 UGT#A# * 59 plasma folate 59 hyperplastic 59 proteomic analysis 59 serum ALT 59 TMPRSS2 ERG 59 PBMCs 59 TEAEs 59 proteoglycan 59 serum markers 59 LAB CGRP 59 non Hodgkin lymphomas 59 myopathy rhabdomyolysis 59 GRASPA ® 59 5-fluorouracil/leucovorin 59 Cytogenetic 59 anterior pituitary 59 PREVENT IV 59 interstitial fibrosis 59 trabectedin 59 herpetic keratitis 59 plasma renin activity 59 biodistribution studies 59 urticaria hives 59 hematologic adverse 59 total thyroidectomy 59 Soft Tissue Sarcoma 59 EBV infection 59 ovarian carcinoma 59 cardiac troponin T 59 hyperinsulinemic euglycemic clamp 59 standard chemotherapy regimens 59 HER2 positive cancers 59 HBeAg negative 59 transplantation HSCT 59 thymoma 59 exocrine 59 allogeneic hematopoietic stem cell 59 CHOP chemotherapy 59 redox active 59 cervical carcinoma 59 Val HeFT 59 serum calcium levels 59 refractory chronic lymphocytic 59 myeloid 59 lymphocyte proliferation 59 preoperative PSA 59 plasma selenium 59 microdose 59 Tr DNA 59 psychiatric comorbidity 59 vasodilatory 59 adipogenic 59 procalcitonin 59 hemodilution 59 UGT#A# 58 Elevated serum 58 multivariable analyzes 58 neurite outgrowth 58 lupus anticoagulant 58 neurogenic 58 hypersensitivity allergic reactions 58 daily subcutaneous injections 58 renal fibrosis 58 methicillin susceptible Staphylococcus aureus 58 preoperative diagnosis 58 NOD SCID mice 58 Dacogen decitabine 58 osteogenic 58 diagnostic biomarker 58 idiopathic PAH 58 myelosuppression 58 ragweed allergic 58 mutated KRAS 58 Squalamine 58 pharmacodynamic biomarkers 58 underwent surgical resection 58 fallopian tube cancers 58 H. pylori eradication 58 cMET 58 recovery CRp 58 ß blockers 58 leucopenia 58 Relapsing remitting MS 58 MAGE A3 ASCI 58 cytoprotective 58 adrenocortical 58 histopathology 58 neurocognitive outcomes 58 testicular germ cell 58 APTIMA HPV 58 malignant neoplasm 58 elacytarabine 58 serum IGF 58 aplastic anemia AA 58 serum estradiol 58 Severe Primary IGFD 58 antidiabetic drugs 58 adrenocortical cancer 58 Myelodysplastic syndromes MDS 58 novel VDA molecule 58 endometrial hyperplasia 58 ELISPOT 58 trans retinoic acid 58 multivariate analyzes 58 TIMP 58 monoclonal anti 58 hypogonadal 58 pediatric acute lymphoblastic 58 cardiac dysfunction 58 TMP SMX 58 vWD 58 percutaneous biopsy 58 tumor malignancies 58 chemosensitivity 58 tonsillar hypertrophy 58 anemias 58 underwent radical prostatectomy 58 oncogenic transformation 58 cytokeratin 58 complete cytogenetic response 58 antiangiogenesis 58 potent antiproliferative 58 taxane resistant 58 hypocalcaemia 58 Cutaneous T 58 comorbid psychiatric 58 motor neuron degeneration 58 ALT elevation 58 imatinib therapy 58 murine model 58 recurrent miscarriage 58 osteochondroma 58 PTHrP 58 chloride secretion 58 follicular thyroid cancer 58 nitrofurantoin 58 sonographic appearance 58 RezularTM 58 cytogenetic response 58 NATRECOR ® 58 serum calcium 58 urothelial cancer 58 NGAL 58 macrolide antibiotic 58 CP CPPS 58 alkylating agent 58 CD4 + CD# 58 pyrimidine 58 serum bilirubin 58 Renal impairment 58 GISTs 58 molecular biomarkers 58 pyridostigmine 58 sputum induction 58 Hashimoto thyroiditis 58 pathologic diagnosis 58 breast pancreatic 58 TNF blocker therapy 58 Meta analyzes 58 nadolol